BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-17 4:52 pm Purchase |
2023-11-15 | 13D | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.500% |
1,235,000 (+13.57%) |
Filing |
| 2023-11-03 5:20 pm Purchase |
2023-11-02 | 13D | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.600% |
806,612 (+9.73%) |
Filing |
| 2023-02-13 5:55 pm Purchase |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% |
150,000 (+1.84%) |
Filing |
| 2022-06-06 5:25 pm Purchase |
2022-06-02 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.400% |
3,283,227 (+67.57%) |
Filing |
| 2022-02-11 9:11 pm Purchase |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.600% |
1,136,363 (+30.53%) |
Filing |
| 2021-03-16 5:18 pm Purchase |
2021-03-12 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.100% |
750,207 (+25.24%) |
Filing |
| 2021-02-12 4:22 pm Purchase |
2020-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 2,972,191 8.100% |
1,027,645 (+52.85%) |
Filing |
| 2020-06-29 6:25 pm Purchase |
2020-06-19 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 1,944,546 5.300% |
1,944,546 (New Position) |
Filing |